Bacterial Sepsis: Clinical Trials

1 trial for Bacterial Sepsis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1

Follow Bacterial Sepsis: new trials by email Literature Review of Bacterial Sepsis trials Research Report on Bacterial Sepsis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Detoxified J5 Core Glycolipid/ Group B Meningococcal Outer Membrane Protein Vaccine for Gram-negative Bacterial Sepsis Administered With and Without Synthetic CPG Oligodeoxynucleotide 7909 Adjuvant
CPG 7909, J5-OMP Vaccine, Placebo - Bacterial Sepsis
Phase 1TerminatedNational Institute of Allergy and Infectious Diseases (NIAID)202011-11-012014-01-31

Narrower conditions

Sepsis (1)

Broader conditions

Infections (1)  ·  Inflammation (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Systemic Inflammatory Response Syndrome (1)

Interventions

ProMune (1)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (1)

Countries

United States (1)

Results publications

PMID 26514420